乐鱼在线

Reliable Quality

Affordable Innovation

Name	Indication	Clinical Trial Phase	Study Title
HLX10	MSI-H Solid Malignant Tumor	Phase II	A Clinical Study to Evaluate HLX10 Monotherapy for the Treatment of MSI-H or dMMR Solid Tumors That Failed to Respond to Standard Therapy
HLX20	Advanced Soild Tumours	Phase I	A Phase I Study of HLX20, a Human Monoclonal Antibody Targeting PD-L1Protein in Patients with Advanced Solid Tumors
HLX22	Soild Tumours	Phase I	Evaluate Safety, Tolerability and Pharmacokinetics of HLX22 in Patients With Advanced Solid Tumors Overexpressing HER2
HLX12	Healthy Male Subjects	Phase I	A Phase I Study Comparinge Pharmacokinetic, Safety, Tolerability and Immunogenicity of HLX12 and Ramucirumab in Healthy Male Adult Subjects
HLX07	Advanced Soild Tumours	Phase Ib/II	The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined with Chemotherapy in Advanced Solid Tumors

var _hmt = _hmt || []; (function() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })(); !function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7iMpaU8NS42Fm",ck:"K9y7iMpaU8NS42Fm"}); 乐鱼在线官网-乐鱼在线 ufc下注官网_ufc竞猜平台【新版本下载】 ufc下注_ufc押注网站 ufc下注官网_ufc竞猜软件【注册登录】天博APP-天博APP下载-天博APP官方网站